A novel approach to enhance ethanol infusion utility in the non-visualized vein of Marshall
Using the VV as a landmark can enhance the feasibility of the EIVOM procedure. Despite this novel technique, EVIOM did not improve AF ablation outcomes. These findings regarding unveiled VOMs are preliminary, and are limited by the small sample size of this group.
Authors
- Yoshio Kobayashi (ORCID: https://orcid.org/0000-0002-6268-6883)
- Minami Matsuno
- Toshiharu Himi
- Y. Watanabe (ORCID: https://orcid.org/0009-0007-8298-032X)
- Masayuki Ishimura (ORCID: https://orcid.org/0000-0002-6563-9150)
- Masashi Yamamoto (ORCID: https://orcid.org/0000-0002-9447-6602)
- Akiko Yoshimori
Institutions
- Kisarazu Hospital (JP)
- Chiba University Hospital (JP)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1016/j.hroo.2025.08.005
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Takeda Pharmaceutical Company
- Boston Scientific Corporation
- Abbott Japan
- Boehringer Ingelheim Japan
- Daiichi-Sankyo
- Otsuka Pharmaceutical
- Pfizer Japan
- Amgen Astellas Biopharma
- Medtronic Japan